
Lavidiclo 75mg Injection
Marketer
Lavish Biotech
Salt Composition
Diclofenac (75mg)
Overview Lavidiclo 75mg Injection
A 75mg injection of Lavidiclo provides pain relief. Indicated for pain, inflammation, joint stiffness, and arthritic pain (rheumatoid, osteoarthritis, and acute musculoskeletal injuries), it's administered intravenously when oral intake is infeasible. Administering this injection requires a healthcare professional; self-injection is strictly prohibited. Patients with a history of cardiac events or stroke should inform their physician. Report injection site reactions (pain, swelling, redness) immediately. Common adverse effects include nausea, vomiting, headache, and injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, and blood counts. Serious complications, including gastrointestinal bleeding and kidney dysfunction, are potential risks associated with extended use.
Primary Ingredients of Lavidiclo 75mg Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Lavidiclo 75mg Injection
Analgesia
Major Benefits of Lavidiclo 75mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Lavidiclo 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Lavidiclo 75mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lavidiclo 75mg Injection works:
Lavidiclo 75mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Using Lavidiclo 75mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Lavidiclo 75mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Administering Lavidiclo 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Lavidiclo 75mg Injection may induce adverse reactions that could impair driving capabilities.
KidneyCAUTION
The administration of Lavidiclo 75mg Injection requires careful consideration in individuals with impaired renal function. A modified dosage of Lavidiclo 75mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Lavidiclo 75mg Injection cautiously. Dosage modification of Lavidiclo 75mg Injection might be necessary. Physician consultation is recommended.
What if you forget to take Lavidiclo 75mg Injection :
Omit a scheduled Lavidiclo 75mg Injection? Seek your physician's advice.
Facts to Know About Lavidiclo 75mg Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
